skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Merlevede, Jane ; Droin, Nathalie ; Qin, Tingting ; Meldi, Kristen ; Yoshida, Kenichi ; Morabito, Margot ; Chautard, Emilie ; Auboeuf, Didier ; Fenaux, Pierre ; Braun, Thorsten ; Itzykson, Raphael ; de Botton, Stéphane ; Quesnel, Bruno ; Commes, Thérèse ; Jourdan, Eric ; Vainchenker, William ; Bernard, Olivier ; Pata-Merci, Noemie ; Solier, Stéphanie ; Gayevskiy, Velimir ; Dinger, Marcel E ; Cowley, Mark J ; Selimoglu-Buet, Dorothée ; Meyer, Vincent ; Artiguenave, François ; Deleuze, Jean-François ; Preudhomme, Claude ; Stratton, Michael R ; Alexandrov, Ludmil B ; Padron, Eric ; Ogawa, Seishi ; Koscielny, Serge ; Figueroa, Maria ; Solary, Eric

Nature communications, 2016-02, Vol.7 (1), p.10767-10767, Article 10767 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study
Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

VAN LAETHEM, Jean-Luc ; HAMMEL, Pascal ; COLLETTE, Laurence ; BUDACH, Volker ; LUTZ, Manfred ; VAN CUTSEM, Eric ; HAUSTERMANS, Karin ; MORNEX, Françoise ; AZRIA, David ; VAN TIENHOVEN, Geertjan ; VERGAUWE, Philippe ; PEETERS, Marc ; POLUS, Marc ; PRAET, Michel ; MAUER, Murielle

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4450-4456 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer

Adiseshaiah, Pavan P ; Crist, Rachael M ; Hook, Sara S ; McNeil, Scott E

Nature reviews. Clinical oncology, 2016-12, Vol.13 (12), p.750-765 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Wei, Andrew H ; Döhner, Hartmut ; Pocock, Christopher ; Montesinos, Pau ; Afanasyev, Boris ; Dombret, Hervé ; Ravandi, Farhad ; Sayar, Hamid ; Jang, Jun-Ho ; Porkka, Kimmo ; Selleslag, Dominik ; Sandhu, Irwindeep ; Turgut, Mehmet ; Giai, Valentina ; Ofran, Yishai ; Kizil Çakar, Merih ; Botelho de Sousa, Aida ; Rybka, Justyna ; Frairia, Chiara ; Borin, Lorenza ; Beltrami, Germana ; Čermák, Jaroslav ; Ossenkoppele, Gert J ; La Torre, Ignazia ; Skikne, Barry ; Kumar, Keshava ; Dong, Qian ; Beach, C.L ; Roboz, Gail J

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Seufferlein, T ; Bachet, J B ; Van Cutsem, E ; Rougier, P

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii33-vii40 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
6
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML

Lancet, Jeffrey E. ; Cortes, Jorge E. ; Hogge, Donna E. ; Tallman, Martin S. ; Kovacsovics, Tibor J. ; Damon, Lloyd E. ; Komrokji, Rami ; Solomon, Scott R. ; Kolitz, Jonathan E. ; Cooper, Maureen ; Yeager, Andrew M. ; Louie, Arthur C. ; Feldman, Eric J.

Blood, 2014-05, Vol.123 (21), p.3239-3246 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
Material Type:
Artigo 		Adicionar ao Meu Espaço

We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine

Lemberg, Kathryn M ; Vornov, James J ; Rais, Rana ; Slusher, Barbara S

Molecular cancer therapeutics, 2018-09, Vol.17 (9), p.1824-1832 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Burtness, Barbara ; Greil, Richard ; de Castro, Gilberto ; Fuereder, Thorsten ; Ngamphaiboon, Nuttapong ; Wan Ishak, Wan Zamaniah ; Hong, Ruey-Long ; González Mendoza, René ; Zhang, Yayan ; Gumuscu, Burak ; Boyer, Michael ; Hughes, Brett ; Rischin, Danny ; Taylor, Anne ; Burian, Martin ; Barrios, Carlos Henrique ; de Castro Junior, Dalvaro Oliveira ; Franke, Fabio Andre ; Girotto, Gustavo ; Lima, Iane Pinto Figueiredo ; Nicolau, Ulisses Ribaldo ; Santos, Lucas ; Victorino, Ana-Paula ; Chua, Neil ; Couture, Felix ; Hansen, Aaron ; Hilton, John ; McCarthy, Joy ; Soulieres, Denis ; Ascui, Rodrigo ; Villanueva, Luis ; Kral, Zdenek ; Prausova, Jana ; Vosmik, Milan ; Jurgens, Hannes ; Putnik, Kadri ; Gruenwald, Viktor ; Boukovinas, Ioannis ; Psyrri, Amanda ; Kwong, Dora ; Csoszi, Tibor ; Horvai, Geza ; Landherr, Laszlo ; Szota, Judit ; Billan, Salem ; Nole, Franco ; Fujimoto, Yasushi ; Hanai, Nobuhiro ; Hara, Hiroki ; Shimizu, Yasushi ; Sugasawa, Masashi ; Takahashi, Shunji ; Tanaka, Kaoru ; Ueda, Tsutomu ; Wan Ishak, Wan Zamaniah ; Gonzalez Mendoza, Rene ; Buter, Jan ; Hoeben, Ann ; Bratland, Aase ; Querol, John ; Regala, Eugenio Emmanuel ; Villegas, Ellie May ; Karpenko, Andrey ; Zarubenkov, Oleg ; Cohen, Graham ; du Toit, Johanna ; Jordaan, Christa ; Landers, Gregory ; Ruff, Paul ; Tabane, Neonyana ; Brana, Irene ; Iglesias Docampo, Lara ; Abel, Edvard ; Muratidu, Valentina ; Nielsen, Niels ; Cristina, Valerie ; Rothschild, Sacha ; Yang, Muh-Hwa ; Yeh, Su-Peng ; Ngamphaiboon, Nuttapong ; Cicin, Irfan ; Ekenel, Meltem ; Harrington, Kevin ; Ali, Haythem ; Anderson, Daniel ; Bruce, Justine ; Halmos, Balazs ; Hegde, Upendra ; Khan, Saad ; Martincic, Danko ; McCune, Steven ; Misiukiewicz, Krzysztof ; Neupane, Prakash ; Nunnink, Johannes ; O'Malley, Meaghan ; Powell, Steven ; Redman, Rebecca ; Rella, Vincent ; Rocha Lima, Chaio ; Wong, Stuart

The Lancet (British edition), 2019-11, Vol.394 (10212), p.1915-1928 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer
A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer

Dimcevski, Georg ; Kotopoulis, Spiros ; Bjånes, Tormod ; Hoem, Dag ; Schjøtt, Jan ; Gjertsen, Bjørn Tore ; Biermann, Martin ; Molven, Anders ; Sorbye, Halfdan ; McCormack, Emmet ; Postema, Michiel ; Gilja, Odd Helge

Journal of controlled release, 2016-12, Vol.243, p.172-181 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
10
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Von Hoff, Daniel D ; Ervin, Thomas ; Arena, Francis P ; Chiorean, E. Gabriela ; Infante, Jeffrey ; Moore, Malcolm ; Seay, Thomas ; Tjulandin, Sergei A ; Ma, Wen Wee ; Saleh, Mansoor N ; Harris, Marion ; Reni, Michele ; Dowden, Scot ; Laheru, Daniel ; Bahary, Nathan ; Ramanathan, Ramesh K ; Tabernero, Josep ; Hidalgo, Manuel ; Goldstein, David ; Van Cutsem, Eric ; Wei, Xinyu ; Iglesias, Jose ; Renschler, Markus F

The New England journal of medicine, 2013-10, Vol.369 (18), p.1691-1703 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (7.894)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (8.419)
  2. Anais de Congresso  (10)
  3. magazinearticle  (9)
  4. Livros  (4)
  5. Web Resources  (1)
  6. Newsletter Articles  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1975  (47)
  2. 1975Até1986  (109)
  3. 1987Até1998  (925)
  4. 1999Até2011  (4.498)
  5. Após 2011  (2.868)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (8.068)
  2. Japonês  (1.066)
  3. Francês  (129)
  4. Alemão  (101)
  5. Espanhol  (52)
  6. Italiano  (42)
  7. Português  (22)
  8. Holandês  (18)
  9. Russo  (15)
  10. Chinês  (14)
  11. Coreano  (8)
  12. Húngaro  (5)
  13. Hebraico  (5)
  14. Tcheco  (4)
  15. Norueguês  (4)
  16. Sueco  (4)
  17. Dinamarquês  (4)
  18. Eslovaco  (1)
  19. Ucraniano  (1)
  20. Búlgaro  (1)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.